- Home
- IMUX vs SCWO Comparison
IMUX vs SCWO Comparison
Compare IMUX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- SCWO
- Stock Information
- Founded
- IMUX 2016
- SCWO 2021
- Country
- IMUX United States
- SCWO United States
- Employees
- IMUX N/A
- SCWO N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- SCWO Environmental Services
- Sector
- IMUX Health Care
- SCWO Utilities
- Exchange
- IMUX Nasdaq
- SCWO Nasdaq
- Market Cap
- IMUX 67.8M
- SCWO 56.4M
- IPO Year
- IMUX N/A
- SCWO N/A
- Fundamental
- Price
- IMUX $0.81
- SCWO $0.19
- Analyst Decision
- IMUX Strong Buy
- SCWO
- Analyst Count
- IMUX 6
- SCWO 0
- Target Price
- IMUX $11.60
- SCWO N/A
- AVG Volume (30 Days)
- IMUX 1.8M
- SCWO 1.3M
- Earning Date
- IMUX 08-07-2025
- SCWO 08-13-2025
- Dividend Yield
- IMUX N/A
- SCWO N/A
- EPS Growth
- IMUX N/A
- SCWO N/A
- EPS
- IMUX N/A
- SCWO N/A
- Revenue
- IMUX N/A
- SCWO $673,267.00
- Revenue This Year
- IMUX N/A
- SCWO $5,945.19
- Revenue Next Year
- IMUX N/A
- SCWO $106.82
- P/E Ratio
- IMUX N/A
- SCWO N/A
- Revenue Growth
- IMUX N/A
- SCWO 161.19
- 52 Week Low
- IMUX $0.56
- SCWO $0.16
- 52 Week High
- IMUX $2.11
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- IMUX 54.61
- SCWO 34.63
- Support Level
- IMUX $0.68
- SCWO $0.16
- Resistance Level
- IMUX $0.83
- SCWO $0.44
- Average True Range (ATR)
- IMUX 0.05
- SCWO 0.06
- MACD
- IMUX 0.02
- SCWO -0.02
- Stochastic Oscillator
- IMUX 89.29
- SCWO 14.54
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.